Causaly accelerates the acquisition of knowledge and insights in biomedicine by leveraging its advanced AI platform. Founded in 2018, Causaly provides access to millions of academic publications, clinical trials, regulatory documents, and patents, enabling researchers and decision-makers to extract valuable evidence quickly. The platform is built on a high-precision Knowledge Graph and is used by major biopharma companies and institutions for applications such as drug discovery, safety assessments, and competitive intelligence. Committed to promoting scientific breakthroughs, Causaly values diversity, equity, and inclusion, fostering an environment where every team member can contribute uniquely. The company is backed by leading venture capital firms and prioritizes collaboration among its interdisciplinary teams to create impactful solutions in the life sciences sector.